Dr Dale Morrison presents at ADC 2025
We would like to congratulate Dr Dale Morrison for his presentations at ADC 2025 this week. Dale gave two presentations:
Whey protein intervention to mitigate hypoglycaemia risk in people with type 1 diabetes
In people with type 1 diabetes (T1D), ingestion of fast-absorbing protein (e.g. whey protein) stimulates glucagon secretion. This study aims to characterise the glycaemic response to whey protein ingestion in T1D. It was found that whey protein ingestion stimulates glucagon secretion in a dose-dependent manner in people with T1D. While high dose protein increased peak glucose to a greater degree than low dose protein, rate of increase was similar. This provides initial data demonstrating the potential for whey protein to mitigate hypoglycaemia in T1D.
Glycaemic Impact of the Pre-Exercise Timing of an Elevated Glucose Target Implemented Using an Automated Insulin Delivery System in Adults with Type 1 Diabetes
Pre-exercise recommendations for people with type 1 diabetes (T1D) using automated insulin delivery often involve planning exercise well in advance, such as setting a temporary elevated glucose target 1-2h pre-exercise. This study compares glucose control in adults with T1D using AID when a temporary target is set closer to exercise. This study found that glycaemia with exercise was excellent regardless of temporary target timing, which had minimal impact on glycaemic outcomes during and post-exercise in a well-controlled cohort in the absence of a recent meal. While implementation of a temporary target 60min pre-exercise as currently recommended has an impact on insulin delivery pre-exercise, the glycaemic benefits are minor and this recommendation could be liberalised in some cases.
Dr Dale Morrison presents at ADC 2025
We would like to congratulate Dr Dale Morrison for his presentations at ADC 2025 this week. Dale gave two presentations:
Whey protein intervention to mitigate hypoglycaemia risk in people with type 1 diabetes
In people with type 1 diabetes (T1D), ingestion of fast-absorbing protein (e.g. whey protein) stimulates glucagon secretion. This study aims to characterise the glycaemic response to whey protein ingestion in T1D. It was found that whey protein ingestion stimulates glucagon secretion in a dose-dependent manner in people with T1D. While high dose protein increased peak glucose to a greater degree than low dose protein, rate of increase was similar. This provides initial data demonstrating the potential for whey protein to mitigate hypoglycaemia in T1D.
Glycaemic Impact of the Pre-Exercise Timing of an Elevated Glucose Target Implemented Using an Automated Insulin Delivery System in Adults with Type 1 Diabetes
Pre-exercise recommendations for people with type 1 diabetes (T1D) using automated insulin delivery often involve planning exercise well in advance, such as setting a temporary elevated glucose target 1-2h pre-exercise. This study compares glucose control in adults with T1D using AID when a temporary target is set closer to exercise. This study found that glycaemia with exercise was excellent regardless of temporary target timing, which had minimal impact on glycaemic outcomes during and post-exercise in a well-controlled cohort in the absence of a recent meal. While implementation of a temporary target 60min pre-exercise as currently recommended has an impact on insulin delivery pre-exercise, the glycaemic benefits are minor and this recommendation could be liberalised in some cases.